When we read about college and youth sports today, it’s usually about the dangers to health – mainly, concussions. However, a new study led by Nina Kraus, PhD, director of Northwestern’s Auditory Neuroscience Laboratory, BrainVolts, has found that athletes have healthier brains than non-athletes. 

Northwestern Medicine cardiologists Clyde Yancy, MD, and Donald Lloyd-Jones, MD, share tips to lose weight or maintain weight and live longer, healthier lives in 2020.

Two Northwestern physician-scientists, Clyde Yancy, MD, and Donald Lloyd-Jones, MD, share their thoughts on the latest findings and advances in cardiology to come in 2020. 

It is the most common tumor found in women and is the cause of 200,000 hysterectomies in the United States every year. Yet, uterine fibroids have not been a frequent topic of medical research. Northwestern’s Serdar Bulun, MD, leads one of the few research programs focused on the molecular and cellular abnormalities that may cause uterine fibroids and is investigating novel targets to treat the condition.

In a recent Northwestern Medicine study published in the New England Journal of Medicine, female surgical residents reported more mistreatment than men, which was linked to a higher burnout rates and more suicidal thoughts. Study authors Karl Bilimoria, MD & Yue-Yung Hu, MD explain.

Elizabeth McNally, MD, PhD, talks about her recent discoveries in the genetics of cardiovascular and neuromuscular disorders and what we can expect in the next few years in the field of genetic medicine.

For those with advanced metastatic prostate cancer, treatments are limited, but a new phase 3 international trial shows that a genetically targeted therapy could offer new hope for patients with specific gene mutations in their tumors. Northwestern’s Maha Hussain, MD, recently presented the results of this landmark trial and shares her insight.

Ali Shilatifard, PhD, hopes his discoveries will lead to a super drug that could end childhood leukemia and other cancers.

Northwestern scientists are conducting dozens of experiments and clinical trials aimed at understanding and fighting glioblastoma, the most common and aggressive primary brain tumor in adults. Rimas Lukas, MD, shares results of a promising Phase 1 clinical trial and other projects underway.